Levels of SUMO3 were not measured here, but where both SUMO3 and PRMT2 are overexpressed, the consequences for regulation of activity levels of the hormone receptors will further complicate predictions for phenotypic features in DS. This evidence concerns the gene NR4A1 and Dravet syndrome.